Log in to save to my catalogue

Oral administration of butylated hydroxytoluene induces neuroprotection in a streptozotocin-induced...

Oral administration of butylated hydroxytoluene induces neuroprotection in a streptozotocin-induced...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d1011b3252b422a8f183d9c69122c08

Oral administration of butylated hydroxytoluene induces neuroprotection in a streptozotocin-induced rat Alzheimer's disease model via inhibition of neuronal ferroptosis

About this item

Full title

Oral administration of butylated hydroxytoluene induces neuroprotection in a streptozotocin-induced rat Alzheimer's disease model via inhibition of neuronal ferroptosis

Publisher

England: Springer

Journal title

Molecular Medicine, 2024-11, Vol.30 (1), p.204-19, Article 204

Language

English

Formats

Publication information

Publisher

England: Springer

More information

Scope and Contents

Contents

Alzheimer's disease (AD) is the most common human neurodegenerative disorder worldwide. Owing to its chronic nature, our limited understanding of its pathophysiological mechanisms, and because of the lack of effective anti-AD drugs, AD represents a significant socio-economic challenge for all industrialized countries. Neuronal cell death is a key f...

Alternative Titles

Full title

Oral administration of butylated hydroxytoluene induces neuroprotection in a streptozotocin-induced rat Alzheimer's disease model via inhibition of neuronal ferroptosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0d1011b3252b422a8f183d9c69122c08

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d1011b3252b422a8f183d9c69122c08

Other Identifiers

ISSN

1528-3658

E-ISSN

1528-3658

DOI

10.1186/s10020-024-00980-y

How to access this item